Trevigen is a Maryland-based company that develops and delivers innovative technologies and systems for the study of cancer, drug development, regenerative medicine, and translational research. The company’s objective is to provide researchers with assays that are innovative and more physiologically relevant. Trevigen is dedicated to the development of 3D culture assays and products and has become an industry leader in that area.